BLISSGVS
162.45
2019-01-04
BLISS GVS PHARMA LTD.
Profitability metrics STANDALONE CONSOLIDATED
Asset Turnover 0.4294 0.9411
Current ratio 10.2 3.41
WC days 655.97 225.28
EBITDA (%) 33.56 0
FCF (Rs Cr.) 23 -5
ROCE (%) 14.8 0
ROE (%) 10.54 11.01

Solvency metrics STANDALONE CONSOLIDATED
Cash Ratio 1.19 0.42
Div. payout (%) 18.09 180
Int. Coverage 13.43 0
LT D/E 0.17 0.22
Solvency Ratio 0.67 0.68

Valuation STANDALONE CONSOLIDATED
Beta 0.6732 0.6732
Div. yield (%) 1 5
EV (Rs Cr.) 2037.77 2043.2
P/BV 3.72 3.76
P/E 35.33 34.14
PEG -5.83 5.33
P/S 6.76 2.47

Balance sheet metrics STANDALONE CONSOLIDATED
BV/share 52.47 51.99
3Y growth BV/s (%) 47 59
Cash (Rs Cr.) 70.29 88.86
Total Debt (Rs Cr.) 94 118
Net block (Rs Cr.) 73 143

P&L metrics STANDALONE CONSOLIDATED
DPS 1 10.3
EPS 5.53 5.72
Net Income (Rs Cr.) 57 59
Operating profit (Rs Cr.) 89 194
No. of o/s shares 10.31 10.31
Revenue (Rs Cr.) 298 815
Total Income (Rs Cr.) 309 811

Cash Flow metrics STANDALONE CONSOLIDATED
CEPS (%) 223 175
3Y growth CEPS 5.76 -0.63
CFF (Rs Cr.) -22 -76
CFI (Rs Cr.) 22 54
CFO (Rs Cr.) 23 18
FCF (Rs Cr.) 23 -5
3Y growth Op. CF (%) 571 -63

Growth metrics STANDALONE CONSOLIDATED
3Y growth dividends (%) 43 1371
1Q growth EBITDA (%) 0 0
3Y growth EBITDA (%) -7 0
4Q growth EBITDA (%) 0 0
1Q growth EPS (%) 0 0
3Y growth EPS (%) -5 -1
4Q growth EPS (%) 0 0
3Y growth Net inc. (%) -5 -2
1Y growth Op. CF (%) -34 -94
1Q growth revenue (%) 0 0
3Y growth revenue (%) -5 100
4Q growth revenue (%) 0 0